Sun Pharma to acquire Organon for Inorganic Growth - The Financial World
Sun Pharma→Organon
May 1, 2026

Channel-specific outreach playbooks for deal origination.
Comparison posts, methodology, and analysis from the Tentt team.
Monthly market reports on M&A and private equity activity.
Free calculators for M&A, lending, and deal analysis.
Origination in the Age of AI.
Vireo Growth has acquired Fluent, a substance abuse treatment business in Florida, for $71.5 million. Vireo Growth acquisitions expand healthcare M&A capabilities by bringing Fluent’s vertically integrated cannabis operations into its Florida footprint, supporting medical cannabis demand across Tampa and the state. Fluent acquisition strengthens Vireo Growth’s platform acquisition strategy with scale in cultivation and production, positioning the combined company as a larger multi-state operator. The all-stock strategic acquisition is a platform acquisition led by a strategic buyer, with deal size in the $50M–$100M range and an announced status pending regulatory approvals in each market.
Filed under
Source
Read full article on globenewswire.comvia GN - entered into definitive agreement · May 1, 2026
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Sun Pharma→Organon
May 1, 2026
United Surgical Partners International→ASCs (seven acquired)
Apr 30, 2026
Volaris Group→Interplayers
Apr 30, 2026
Tenet Healthcare→United Surgical Partners International
Apr 30, 2026
Vitalist→Somatix
Apr 30, 2026